NeoCOAST-2 trial finds early ctDNA clearance in blood tests linked to improved lung cancer outcomes, potentially guiding ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

Damian Doherty, Executive Editor at Inside Precision Medicine, sat down with Magda Kordon-Kiszala, PhD, CEO and co-founder of intoDNA, to explore how a breakthrough in understanding DNA damage and ...

From whole-genome sequencing to magnetic resonance imaging (MRI) and artificial intelligence (AI)-guided diagnostics, these ...

Antibody patterns can signal whether a person will develop inflammatory bowel disease (IBD) up to 10 years before diagnosis.

GLP-1 medications may reduce complications after surgery, with new research linking their use to fewer cardiovascular events ...

A blood test measuring proteins released by the brain after injury could help clinicians identify patients with traumatic brain injury (TBI) who may otherwise go undiagnosed. Published today in the ...

New research reveals how autoimmune kidney inflammation develops and identifies an antibody-based strategy that may prevent ...

A genetic variant present in approximately 16% of individuals of African ancestry and virtually absent in those of European ancestry significantly increases risk for dilated cardiomyopathy. People ...

New research links genomic, transcriptomic, and epigenetic features to treatment response in multiple myeloma.

The U.K. biotech IMU Biosciences will help create a large and detailed immune dataset for 80,000 people in the UK Biobank.